• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number 2AF283
Device Problem Insufficient Information (3190)
Patient Problems Transient Ischemic Attack (2109); Pseudoaneurysm (2605)
Event Date 01/01/2015
Event Type  Injury  
Event Description
Bordignon s, furnkranz a, perrotta l, et al.High rate of durable pulmonary vein isolation after second-generation cryoballoon ablation: analysis of repeat procedures.Europace.2015;17(5):725-731.Aims pulmonary vein isolation (pvi) using the first-generation cryoballoon (cb1) was characterized by a high rate of recovered pulmo nary vein (pv) conduction along with a typical conduction gap pattern in patients with recurrent atrial tachyarrhythmia (ata).Second generation (cb2) enables more uniform freezing.However, the rate of chronic pvi and pv conduction gap pattern is unknown.Methods and results all patients with ata recurrence undergoing a second procedure after cb2 or (historical) cb1 pvi (28 mm) were enrolled.In all patients, a left atrial three-dimensional electronatomic reconstruction was performed.The rates of chronic pvi and localization of pv conduction gaps were determined and compared between cb1 and cb2.Antral pv re-isolation was performed using irrigated-tip radiofrequency current energy ablation.Of 206 patients (cb2), 18 pati ents underwent the repeat procedure after 192 (75:245) days.In 6 of 18 (33%) patients, all pvs were electrically isolated whereas in the remaining 12 patients (66%) at least one pv demonstrated pv reconduction.Of 71 pvs [1 left common pv (lcpv)], 55 pvs (77%) were chronically isolated.The right superior pv (rspv) was characterized by the lowest rate of chronic pvi (rspv: 56%, lspv: 76%, ripv: 83%, lipv: 94%, lcpv: 100%).Compared with cb1, cb2 ablation resulted in a significantly higher rate of chronic pvi (cb2: 77% vs.Cb1: 32%; p <(> <<)> 0.0001) with the greatest improvement along both inferior pvs.Conclusion second-generation cryoballoon atrial fibrillation ablation is associated with a high rate of durable pvi in patients with ata recurrence.The rspv represents the pv with the greatest risk for left atrium-pulmonary vein reconnection.The literature publication reports the following complications: one patient experienced a transient ischemic attack (tia) and one patient experienced a "false aneurysm.".
 
Manufacturer Narrative
Medtronic cryocath was made aware of this event through a search of literature publications.It was not possible to ascertain specific device information from the literature publication or to match the event with previously reported events.Referenced article: bordignon s, furnkranz a, perrotta l, et al.High rate of durable pulmonary vein isolation after second-generation cryoballoon ablation: analysis of repeat procedures.Europace.2015;17(5):725-731.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER
Type of Device
PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
16771 chemin ste-marie
kirkland H9H 5 H3
CA  H9H 5H3
Manufacturer (Section G)
MEDTRONIC CARDIAC RHYTHM HEART FAILURE
8200 coral sea st ne
mounds view MN 55112
Manufacturer Contact
anne schilling
8200 coral sea st ne
mounds view, MN 55112
7635052036
MDR Report Key4952672
MDR Text Key15838411
Report Number3002648230-2015-00205
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P0100010/S01
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 07/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number2AF283
Device Catalogue Number2AF283
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/07/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
-
-